185 related articles for article (PubMed ID: 28736998)
1. Evasin-displaying lactic acid bacteria bind different chemokines and neutralize CXCL8 production in Caco-2 cells.
Škrlec K; Pucer Janež A; Rogelj B; Štrukelj B; Berlec A
Microb Biotechnol; 2017 Nov; 10(6):1732-1743. PubMed ID: 28736998
[TBL] [Abstract][Full Text] [Related]
2. Lactic Acid Bacteria with Concomitant IL-17, IL-23 and TNFα- Binding Ability for the Treatment of Inflammatory Bowel Disease.
Kosler S; Strukelj B; Berlec A
Curr Pharm Biotechnol; 2017; 18(4):318-326. PubMed ID: 28190384
[TBL] [Abstract][Full Text] [Related]
3. Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody.
Zahirović A; Berlec A
Microb Cell Fact; 2022 Jul; 21(1):143. PubMed ID: 35842694
[TBL] [Abstract][Full Text] [Related]
4. Dual Functionalized
Zahirović A; Plavec TV; Berlec A
Front Bioeng Biotechnol; 2022; 10():822823. PubMed ID: 35155394
[TBL] [Abstract][Full Text] [Related]
5. Secretion and surface display of binders of IL-23/IL-17 cytokines and their receptors in Lactococcus lactis as a therapeutic approach against inflammation.
Plavec TV; Klemenčič K; Kuchař M; Malý P; Berlec A
Eur J Pharm Sci; 2023 Nov; 190():106568. PubMed ID: 37619953
[TBL] [Abstract][Full Text] [Related]
6. Differential expression and polarized secretion of CXC and CC chemokines by human intestinal epithelial cancer cell lines in response to Clostridium difficile toxin A.
Kim JM; Kim JS; Jun HC; Oh YK; Song IS; Kim CY
Microbiol Immunol; 2002; 46(5):333-42. PubMed ID: 12139393
[TBL] [Abstract][Full Text] [Related]
7. Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets.
Alenazi Y; Singh K; Davies G; Eaton JRO; Elders P; Kawamura A; Bhattacharya S
Sci Rep; 2018 Apr; 8(1):6333. PubMed ID: 29679010
[TBL] [Abstract][Full Text] [Related]
8. Surface display of the receptor-binding region of the Lactobacillus brevis S-layer protein in Lactococcus lactis provides nonadhesive lactococci with the ability to adhere to intestinal epithelial cells.
Avall-Jääskeläinen S; Lindholm A; Palva A
Appl Environ Microbiol; 2003 Apr; 69(4):2230-6. PubMed ID: 12676705
[TBL] [Abstract][Full Text] [Related]
9. Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice.
Braunersreuther V; Montecucco F; Pelli G; Galan K; Proudfoot AE; Belin A; Vuilleumier N; Burger F; Lenglet S; Caffa I; Soncini D; Nencioni A; Vallée JP; Mach F
Thromb Haemost; 2013 Oct; 110(4):807-25. PubMed ID: 23925450
[TBL] [Abstract][Full Text] [Related]
10. Glutamine and CXC chemokines IL-8, Mig, IP-10 and I-TAC in human intestinal epithelial cells.
Marion R; Coëffier MM; Gargala G; Ducrotté P; Déchelotte PP
Clin Nutr; 2004 Aug; 23(4):579-85. PubMed ID: 15297094
[TBL] [Abstract][Full Text] [Related]
11. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.
Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ
Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814
[TBL] [Abstract][Full Text] [Related]
12. Tick saliva protein Evasin-3 modulates chemotaxis by disrupting CXCL8 interactions with glycosaminoglycans and CXCR2.
Denisov SS; Ippel JH; Heinzmann ACA; Koenen RR; Ortega-Gomez A; Soehnlein O; Hackeng TM; Dijkgraaf I
J Biol Chem; 2019 Aug; 294(33):12370-12379. PubMed ID: 31235521
[TBL] [Abstract][Full Text] [Related]
13. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine.
Raha AR; Varma NR; Yusoff K; Ross E; Foo HL
Appl Microbiol Biotechnol; 2005 Jul; 68(1):75-81. PubMed ID: 15635459
[TBL] [Abstract][Full Text] [Related]
14. The role of CXC chemokines and their receptors in cancer.
Vandercappellen J; Van Damme J; Struyf S
Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
[TBL] [Abstract][Full Text] [Related]
15. Phylogenetic Analysis Indicates That Evasin-Like Proteins of Ixodid Ticks Fall Into Three Distinct Classes.
Bhattacharya S; Nuttall PA
Front Cell Infect Microbiol; 2021; 11():769542. PubMed ID: 34746035
[TBL] [Abstract][Full Text] [Related]
16. Improvement of LysM-mediated surface display of designed ankyrin repeat proteins (DARPins) in recombinant and nonrecombinant strains of Lactococcus lactis and Lactobacillus Species.
Zadravec P; Štrukelj B; Berlec A
Appl Environ Microbiol; 2015 Mar; 81(6):2098-106. PubMed ID: 25576617
[TBL] [Abstract][Full Text] [Related]
17. Identification of the pharmacophore of the CC chemokine-binding proteins Evasin-1 and -4 using phage display.
Bonvin P; Dunn SM; Rousseau F; Dyer DP; Shaw J; Power CA; Handel TM; Proudfoot AEI
J Biol Chem; 2014 Nov; 289(46):31846-31855. PubMed ID: 25266725
[TBL] [Abstract][Full Text] [Related]
18. Secretion of an immunoreactive single-chain variable fragment antibody against mouse interleukin 6 by Lactococcus lactis.
Shigemori S; Ihara M; Sato T; Yamamoto Y; Nigar S; Ogita T; Shimosato T
Appl Microbiol Biotechnol; 2017 Jan; 101(1):341-349. PubMed ID: 27722916
[TBL] [Abstract][Full Text] [Related]
19. CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue.
Gijsbers K; Van Assche G; Joossens S; Struyf S; Proost P; Rutgeerts P; Geboes K; Van Damme J
Eur J Immunol; 2004 Jul; 34(7):1992-2000. PubMed ID: 15214047
[TBL] [Abstract][Full Text] [Related]
20. A knottin scaffold directs the CXC-chemokine-binding specificity of tick evasins.
Lee AW; Deruaz M; Lynch C; Davies G; Singh K; Alenazi Y; Eaton JRO; Kawamura A; Shaw J; Proudfoot AEI; Dias JM; Bhattacharya S
J Biol Chem; 2019 Jul; 294(29):11199-11212. PubMed ID: 31167786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
